Global Finance Changes
0
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes Global Finance Changes
Global Finance Changes Global Finance Changes
Global Finance Changes Global Finance Changes
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes Global Finance Changes
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes > Investing > RAD 202 receives approval to start Phase 1 therapeutic trial
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0 Shares
Share on Facebook Share on Twitter Share on Pinterest Share on Email
admin December 20, 2024
Previous Article Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
Next Article Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt

You Might Also Enjoy

Terra Clean Energy

July 1, 2025
READ MORE

Zijin Mining to Acquire Major Kazakh Gold Mine for US$1.2 Billion

July 1, 2025
READ MORE

Terra Clean Energy: Advancing an Expansive Uranium Landholding in the Prolific Athabasca Basin

July 1, 2025
READ MORE

South Harz Potash Limited

July 1, 2025
READ MORE
  • Privacy Policy
  • Terms & Conditions

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.


    • Privacy Policy
    • Terms & Conditions
    Copyright © 2025 globalfinancechanges.com | All Rights Reserved

    Our website uses cookies to improve your experience. Learn more about: Cookie Policy

    Accept